放射增敏剂
放射治疗
肿瘤微环境
医学
癌症研究
癌症
肿瘤细胞
癌症治疗
药物输送
生物相容性材料
免疫系统
癌症治疗
治疗方式
癌细胞
细胞
治疗方式
免疫疗法
临床试验
辐射耐受性
医学物理学
输送系统
肿瘤科
临床治疗
模式
作者
Yaxin Cao,Chunxiang Mo,Qing Chen,Jianbo Wang,Bo Pan,Jia Li,Jibin Song,Ling Chen
摘要
Tumor radiotherapy is one of the core modalities in comprehensive clinical cancer treatment. However, the inherent radiation resistance of tumor cells, radiotherapy resistance mediated by the tumor microenvironment, and irreversible damage to normal tissues caused by radiotherapy severely limit its clinical efficacy. Although various radiosensitizers have been developed to enhance radiation-induced tumor damage, their clinical translation largely depends on efficient and tumor-specific delivery systems. This review first summarizes the biological basis of radiosensitization and the major classes of radiosensitizers and then focuses on recent advances in biomimetic delivery platforms designed to improve tumor targeting, microenvironment modulation, and immune activation. Collectively, cell membrane-coated biomimetic nanoplatforms represent a promising strategy for integrating precise radiosensitizer delivery with tumor microenvironment modulation to enhance radiotherapy efficacy. Future work should be dedicated to optimizing membrane engineering, designing multifunctional nanoparticles, and developing manufacturing strategies for clinical translation, thereby accelerating their implementation in precision radiotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI